Reneo Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
RPHM
CUSIP
75974E103
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 75974E103 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
RiverVest Venture Fund III, L.P. 13D/A
1.6% 1/21/2025
Event 1/16/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q4 1 504 $1.46k
2024 Q3 52 28.8 M $49.0M
2024 Q2 67 27.3 M $41.3M
2024 Q1 64 27.4 M $45.4M
2023 Q4 73 25.3 M $40.4M
2023 Q3 59 27.4 M $208M
2023 Q2 53 26.2 M $169M
2023 Q1 36 17.1 M $102M
2022 Q4 33 16.5 M $38.4M
2022 Q3 34 16.5 M $55.1M
2022 Q2 34 16.4 M $43.3M
2022 Q1 42 17.3 M $50.8M
2021 Q4 40 17.4 M $149M
2021 Q3 39 18.4 M $137M
2021 Q2 39 18.3 M $171M